Company

Novo Integrated Sciences is a U.S. based parent company, publicly-traded on the OTC Markets Group (OTC:NVOS), with both U.S. and Canadian based wholly owned subsidiaries. Currently, the Company’s revenue is generated solely by services and products provided by NHL’s team of multidisciplinary primary care clinicians and practitioners in Canada.